UK markets close in 7 hours 12 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
112.12+3.69 (+3.40%)
At close: 04:00PM EDT
115.32 +3.20 (+2.85%)
Pre-market: 04:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 243.86B
Enterprise value 244.61B
Trailing P/E 35.47
Forward P/E 32.15
PEG ratio (5-yr expected) 2.08
Price/sales (ttm)11.75
Price/book (mrq)25.97
Enterprise value/revenue 1.64
Enterprise value/EBITDA 3.58

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 334.66%
S&P500 52-week change 3-8.83%
52-week high 3122.16
52-week low 382.82
50-day moving average 3109.97
200-day moving average 3106.65

Share statistics

Avg vol (3-month) 31.48M
Avg vol (10-day) 31.35M
Shares outstanding 52.27B
Implied shares outstanding 6N/A
Float 81.63B
% held by insiders 10.00%
% held by institutions 18.29%
Shares short (30 May 2022) 41.71M
Short ratio (30 May 2022) 41.03
Short % of float (30 May 2022) 4N/A
Short % of shares outstanding (30 May 2022) 40.08%
Shares short (prior month 28 Apr 2022) 41.73M

Dividends & splits

Forward annual dividend rate 41.57
Forward annual dividend yield 41.49%
Trailing annual dividend rate 310.40
Trailing annual dividend yield 39.59%
5-year average dividend yield 42.13
Payout ratio 447.80%
Dividend date 304 Apr 2022
Ex-dividend date 424 Mar 2022
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 33.11%
Operating margin (ttm)42.61%

Management effectiveness

Return on assets (ttm)23.45%
Return on equity (ttm)78.92%

Income statement

Revenue (ttm)149.03B
Revenue per share (ttm)65.13
Quarterly revenue growth (yoy)24.30%
Gross profit (ttm)117.14B
Net income avi to common (ttm)49.34B
Diluted EPS (ttm)3.03
Quarterly earnings growth (yoy)12.60%

Balance sheet

Total cash (mrq)20.15B
Total cash per share (mrq)8.85
Total debt (mrq)25.48B
Total debt/equity (mrq)38.29
Current ratio (mrq)0.90
Book value per share (mrq)29.24

Cash flow statement

Operating cash flow (ttm)67.33B
Levered free cash flow (ttm)54.22B